• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗环境中难治性高血压的患病率及预测因素:一项横断面研究

Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study.

作者信息

Chia Yook Chin, Ching Siew Mooi

机构信息

Department of Primary Care Medicine, University of Malaya Primary Care Research Group (UMPCRG), Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.

出版信息

BMC Fam Pract. 2014 Jul 5;15:131. doi: 10.1186/1471-2296-15-131.

DOI:10.1186/1471-2296-15-131
PMID:24997591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4094417/
Abstract

BACKGROUND

Patients with resistant hypertension are subjected to a higher risk of getting stroke, myocardial infarction, congestive heart failure and renal failure. However, the exact prevalence of resistant hypertension in treated hypertensive patients in Malaysia is not known. This paper examines the prevalence and determinants of resistant hypertension in a sample of hypertensive patients.

METHODS

We examined the control of blood pressure in a randomly selected sample of patients with hypertension in a primary care clinic. Demographic data, blood pressure and anti-hypertensive drug use were captured from patient records at the end of 2007. Resistant hypertension is defined as failure to achieve target blood pressure of < 140/90 mmHg while on full doses of an appropriate three-drug regimen that includes a diuretic. Multivariate logistic regression was used for the analysis.

RESULTS

A total of 1217 patients with hypertension were entered into the analysis. Mean age of the patients was 66.8 ± 9.7 years and 64.4% were female. More than half of the subjects (56.9%) had diabetes mellitus. Median BP was 130/80 mmHg. Overall prevalence of resistant hypertension was 8.8% (N = 107/1217). In multivariate logistic regression analysis, presence of chronic kidney disease is more likely to be associated with resistant hypertension (odds ratio [OR] 2.89, 95% confidence interval [CI] 1.56-5.35). On the other hand, increase per year of age is associated with lower odds of resistant hypertension in this population (OR 0.96, 95% CI 0.93-0.99).

CONCLUSIONS

Resistant hypertension is present in nearly one in ten hypertensive patients on treatment. Hypertensive patients who have underlying chronic kidney disease are associated with higher odds of having resistant hypertension. Hence, in managing patients with hypertension, primary care physicians should be more alert and identify patients with chronic kidney disease as such patients are more likely to develop resistant hypertension. By doing that, these patients can be treated more aggressively earlier in order to achieve blood pressure target and thus reduce cardiovascular events.

摘要

背景

顽固性高血压患者发生中风、心肌梗死、充血性心力衰竭和肾衰竭的风险更高。然而,马来西亚接受治疗的高血压患者中顽固性高血压的确切患病率尚不清楚。本文研究了高血压患者样本中顽固性高血压的患病率及其决定因素。

方法

我们在一家基层医疗诊所对随机抽取的高血压患者样本的血压控制情况进行了检查。在2007年底从患者记录中获取人口统计学数据、血压和抗高血压药物使用情况。顽固性高血压定义为在使用包括利尿剂在内的适当三联药物全剂量治疗时,未能达到<140/90 mmHg的目标血压。采用多因素逻辑回归进行分析。

结果

共有1217例高血压患者纳入分析。患者的平均年龄为66.8±9.7岁,女性占64.4%。超过一半的受试者(56.9%)患有糖尿病。血压中位数为130/80 mmHg。顽固性高血压的总体患病率为8.8%(N = 107/1217)。在多因素逻辑回归分析中,慢性肾病的存在更有可能与顽固性高血压相关(比值比[OR] 2.89,95%置信区间[CI] 1.56 - 5.35)。另一方面,在该人群中,年龄每增加一岁,患顽固性高血压的几率就越低(OR 0.96,95% CI 0.93 - 0.99)。

结论

接受治疗的高血压患者中,近十分之一患有顽固性高血压。患有潜在慢性肾病的高血压患者患顽固性高血压的几率更高。因此,在管理高血压患者时,基层医疗医生应更加警惕,识别出患有慢性肾病的患者,因为这类患者更有可能发展为顽固性高血压。通过这样做,可以更早地对这些患者进行更积极的治疗,以实现血压目标,从而减少心血管事件。

相似文献

1
Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study.基层医疗环境中难治性高血压的患病率及预测因素:一项横断面研究
BMC Fam Pract. 2014 Jul 5;15:131. doi: 10.1186/1471-2296-15-131.
2
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.冠心病患者中治疗抵抗性高血压的患病率、预测因素和结局。
Am J Med. 2014 Jan;127(1):71-81.e1. doi: 10.1016/j.amjmed.2013.07.038. Epub 2013 Nov 7.
3
PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.PAIT调查随访:轻度至中度慢性肾脏病高血压糖尿病患者蛋白尿的变化
High Blood Press Cardiovasc Prev. 2020 Feb;27(1):43-49. doi: 10.1007/s40292-020-00358-1. Epub 2020 Jan 9.
4
Antihypertensive drugs for elderly patients: a cross- sectional study.老年患者的抗高血压药物:一项横断面研究。
Singapore Med J. 2015 May;56(5):291-7. doi: 10.11622/smedj.2015019.
5
Treatment of 5413 hypertensive patients: a cross-sectional study.治疗 5413 例高血压患者:一项横断面研究。
Fam Pract. 2011 Dec;28(6):599-607. doi: 10.1093/fampra/cmr027. Epub 2011 May 19.
6
Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.老年患者潜在不适当的抗高血压药物处方:一项前瞻性观察性研究的结果
Drugs Aging. 2017 Jun;34(6):453-466. doi: 10.1007/s40266-017-0452-z.
7
Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.日本高血压患者使用 Artist 片剂(卡维地洛)的情况:一项药物使用调查结果。
Drugs R D. 2011;11(2):171-90. doi: 10.2165/11592450-000000000-00000.
8
HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.土耳其的HYT高血压:关于单独使用钙通道阻滞剂或与其他抗高血压药物联合使用时血压控制情况的横断面调查
High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.
9
A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.氨氯地平治疗合并糖尿病和/或肾功能不全的高血压患者的疗效与其他类抗高血压药物的系统评价。
Am J Ther. 2015 Sep-Oct;22(5):322-41. doi: 10.1097/MJT.0000000000000202.
10
Treatment of hypertension in chronic kidney disease.慢性肾脏病高血压的治疗
Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016.

引用本文的文献

1
Predictive Factors of Apparent Treatment Resistant Hypertension Among Patients With Hypertension Identified Using Electronic Health Records.利用电子健康记录识别的高血压患者中貌似难治性高血压的预测因素
J Gen Intern Med. 2025 May;40(6):1265-1274. doi: 10.1007/s11606-024-09068-z. Epub 2024 Oct 2.
2
Prevalence and associated risk factors of resistant hypertension among Chinese hypertensive patients in primary care setting.中国基层医疗环境中高血压患者的耐药高血压患病率及其相关危险因素。
BMC Prim Care. 2024 Apr 19;25(1):120. doi: 10.1186/s12875-024-02366-9.
3
LncRNA H19: A Novel Biomarker in Cardiovascular Disease.长链非编码RNA H19:心血管疾病中的一种新型生物标志物。
Acta Cardiol Sin. 2024 Mar;40(2):172-181. doi: 10.6515/ACS.202403_40(2).20230925A.
4
Management of Hypertension in the Asia-Pacific Region: A Structured Review.亚太地区高血压管理:系统综述。
Am J Cardiovasc Drugs. 2024 Mar;24(2):141-170. doi: 10.1007/s40256-023-00625-1. Epub 2024 Feb 8.
5
Characterizing Hypertension Specialist Care in Canada: A National Survey.加拿大高血压专科护理的特征:一项全国性调查。
CJC Open. 2023 Sep 10;5(12):907-915. doi: 10.1016/j.cjco.2023.08.014. eCollection 2023 Dec.
6
Prevalence, Predictors, and Outcomes of Resistant Hypertension in Egyptian Population.埃及人群中耐药性高血压的流行率、预测因素和结局。
Glob Heart. 2023 Jun 14;18(1):31. doi: 10.5334/gh.1211. eCollection 2023.
7
Hypertension self-care practice and its associated factors in Bale Zone, Southeast Ethiopia: A multi-center cross-sectional study.埃塞俄比亚东南部巴勒地区的高血压自我护理实践及其相关因素:一项多中心横断面研究。
J Pharm Policy Pract. 2023 Feb 2;16(1):20. doi: 10.1186/s40545-022-00508-x.
8
Role of α1-blockers in the current management of hypertension.α1-受体阻滞剂在高血压治疗中的作用。
J Clin Hypertens (Greenwich). 2022 Sep;24(9):1180-1186. doi: 10.1111/jch.14556.
9
Self-care practice among adult hypertensive patients at ambulatory clinic of tertiary teaching Hospital in Ethiopia: a cross-sectional study.埃塞俄比亚三级教学医院门诊成年高血压患者的自我护理实践:一项横断面研究。
J Pharm Policy Pract. 2022 Mar 22;15(1):23. doi: 10.1186/s40545-022-00421-3.
10
Clinical characteristics of two groups commonly referred to an Irish hypertension service-patients with resistant hypertension and young adults with hypertension.两组患者的临床特征——顽固性高血压患者和年轻高血压患者,通常被转诊至爱尔兰高血压服务机构。
Ir J Med Sci. 2022 Dec;191(6):2549-2557. doi: 10.1007/s11845-021-02870-2. Epub 2022 Jan 9.

本文引用的文献

1
Resistant hypertension--its identification and epidemiology.耐药性高血压——其识别与流行病学。
Nat Rev Nephrol. 2013 Jan;9(1):51-8. doi: 10.1038/nrneph.2012.260. Epub 2012 Nov 20.
2
Hypertension in developing countries.发展中国家的高血压。
Lancet. 2012 Aug 11;380(9841):611-9. doi: 10.1016/S0140-6736(12)60861-7.
3
Resistant hypertension.耐药性高血压。
J Am Board Fam Med. 2012 Jul-Aug;25(4):487-95. doi: 10.3122/jabfm.2012.04.110275.
4
Incidence and prognosis of resistant hypertension in hypertensive patients.高血压患者中耐药性高血压的发生率和预后。
Circulation. 2012 Apr 3;125(13):1635-42. doi: 10.1161/CIRCULATIONAHA.111.068064. Epub 2012 Feb 29.
5
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.22 个国家缺血性卒中和脑出血的危险因素研究(INTERSTROKE 研究):一项病例对照研究。
Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.
6
Cardiovascular disease risk in a semirural community in Malaysia.马来西亚一个半乡村社区的心血管疾病风险
Asia Pac J Public Health. 2009 Oct;21(4):410-20. doi: 10.1177/1010539509343973. Epub 2009 Aug 5.
7
Left ventricular hypertrophy, ischemic heart disease and the incidence of cardiovascular events in Japanese high-risk hypertensive patients.日本高危高血压患者的左心室肥厚、缺血性心脏病及心血管事件发生率
Circ J. 2009 Jun;73(6):1014-5. doi: 10.1253/circj.cj-09-0117.
8
Continued improvement in hypertension management in England: results from the Health Survey for England 2006.英格兰高血压管理的持续改善:2006年英格兰健康调查结果
Hypertension. 2009 Mar;53(3):480-6. doi: 10.1161/HYPERTENSIONAHA.108.125617. Epub 2009 Feb 9.
9
Cardiovascular disease and risk factors in Asia: a selected review.亚洲的心血管疾病及风险因素:一篇综述精选
Circulation. 2008 Dec 16;118(25):2702-9. doi: 10.1161/CIRCULATIONAHA.108.790048.
10
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).在抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中按药物组划分的血压控制情况
J Clin Hypertens (Greenwich). 2008 Oct;10(10):751-60. doi: 10.1111/j.1751-7176.2008.00015.x.